Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Dutcher

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Cancer Genetics and Cytogenetics|April 15, 1986
Biphenotypic leukemia with unusual chromosomal translocation in a patient treated for melanomaE Paietta, P Papenhausen, N Ciobanu, et al.
Cancer|November 15, 1988
Adenocarcinoma arising in vulvar breast tissueK E Simon, J P Dutcher, C D Runowicz, et al.
American Journal of Hematology|September 1, 1994
Polyethylene glycolated interleukin-2 as maintenance therapy for acute myelogenous leukemia in second remissionP H Wiernik, J P Dutcher, M Todd, et al.
Medical Oncology (Northwood, London, England)|June 1, 1995
Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cellsE Paietta, D L Nelson, J Andersen, et al.
The Cancer Journal From Scientific American|August 5, 1998
Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991S Wadler, M Atkins, D Karp, et al.
AJR. American Journal of Roentgenology|April 1, 1983
CT of malignant pleural mesotheliomaS Mirvis, J P Dutcher, P J Haney, et al.
Thrombosis Research|August 1, 1995
Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cellsL Oleksowicz, Z Mrowiec, E Schwartz, et al.
Infusionstherapie (Basel, Switzerland)|August 1, 1989
Lymphocytopheresis for killer cell generation and in patients with chronic lymphocytic leukemia: comparison of the COBE 2997 and the COBE SpectraJ P Dutcher, B Wagner, J Ryan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemiaJ P Dutcher, C E Riggs, J J Strauman, et al.
British Journal of Haematology|May 1, 1991
Terminal transferase expression in acute myeloid leukaemia: biology and prognosisR Gucalp, E Paietta, V Weinberg, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Cancer Genetics and Cytogenetics|April 15, 1986
Biphenotypic leukemia with unusual chromosomal translocation in a patient treated for melanomaE Paietta, P Papenhausen, N Ciobanu, et al.
Cancer|November 15, 1988
Adenocarcinoma arising in vulvar breast tissueK E Simon, J P Dutcher, C D Runowicz, et al.
American Journal of Hematology|September 1, 1994
Polyethylene glycolated interleukin-2 as maintenance therapy for acute myelogenous leukemia in second remissionP H Wiernik, J P Dutcher, M Todd, et al.
Medical Oncology (Northwood, London, England)|June 1, 1995
Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cellsE Paietta, D L Nelson, J Andersen, et al.
The Cancer Journal From Scientific American|August 5, 1998
Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991S Wadler, M Atkins, D Karp, et al.
AJR. American Journal of Roentgenology|April 1, 1983
CT of malignant pleural mesotheliomaS Mirvis, J P Dutcher, P J Haney, et al.
Thrombosis Research|August 1, 1995
Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cellsL Oleksowicz, Z Mrowiec, E Schwartz, et al.
Infusionstherapie (Basel, Switzerland)|August 1, 1989
Lymphocytopheresis for killer cell generation and in patients with chronic lymphocytic leukemia: comparison of the COBE 2997 and the COBE SpectraJ P Dutcher, B Wagner, J Ryan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemiaJ P Dutcher, C E Riggs, J J Strauman, et al.
British Journal of Haematology|May 1, 1991
Terminal transferase expression in acute myeloid leukaemia: biology and prognosisR Gucalp, E Paietta, V Weinberg, et al.
Pageof 16